quinazolines has been researched along with Long QT Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bers, DM; Diecke, S; Gong, T; Knowles, JW; Lan, F; Lee, AS; Liang, P; Nguyen, PK; Robbins, RC; Sallam, K; Sanchez-Freire, V; Wang, PJ; Wang, Y; Wu, JC | 1 |
| Fan, ZW; Li, J; Liu, Y; Xu, GG | 1 |
| Cheng, AC; de la Cruz, E; Habeski, WM; Kablaoui, NM; Loh, C; Patel, SD | 1 |
| Beaufils, P; Cabanis, MJ; Extramiana, F; Leenhardt, A; Maison-Blanche, P; Ortemann-Renon, C | 1 |
| Brown, AM; Chen, Y; Danthi, SJ; Eng, H; Kramer, JW; Kuryshev, YA; Lacerda, AE; Renganathan, M; Yang, T | 1 |
1 review(s) available for quinazolines and Long QT Syndrome
| Article | Year |
|---|---|
Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Humans; Hypertension; Long QT Syndrome; Lung Neoplasms; Piperidines; Quinazolines; Randomized Controlled Trials as Topic; Risk | 2015 |
1 trial(s) available for quinazolines and Long QT Syndrome
| Article | Year |
|---|---|
Clinical assessment of drug-induced QT prolongation in association with heart rate changes.
Topics: Adrenergic alpha-Antagonists; Adult; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Predictive Value of Tests; Quinazolines; Quinolines; Reproducibility of Results; Treatment Outcome | 2005 |
3 other study(ies) available for quinazolines and Long QT Syndrome
| Article | Year |
|---|---|
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Topics: Action Potentials; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic, Familial; Cell Differentiation; Cell Line; Cell Size; Cisapride; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Embryoid Bodies; Embryonic Stem Cells; Gene Expression Profiling; Genetic Predisposition to Disease; HEK293 Cells; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Ion Channels; Kidney; Long QT Syndrome; Myocytes, Cardiac; Myofibrils; Nicorandil; Patch-Clamp Techniques; Quinazolines; Verapamil | 2013 |
Quinazolin-4-piperidin-4-methyl sulfamide PC-1 inhibitors: alleviating hERG interactions through structure based design.
Topics: Drug Design; Enzyme Inhibitors; Ether-A-Go-Go Potassium Channels; Humans; Long QT Syndrome; Osteoarthritis; Phosphoric Diester Hydrolases; Piperidines; Protein Binding; Pyrophosphatases; Quinazolines; Sulfonamides | 2009 |
Alfuzosin delays cardiac repolarization by a novel mechanism.
Topics: Action Potentials; Animals; Cell Line; Female; Guinea Pigs; Humans; Long QT Syndrome; Male; Myocytes, Cardiac; Purkinje Fibers; Quinazolines; Rabbits | 2008 |